Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
Mais filtros

País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
4.
BMC Complement Altern Med ; 17(1): 355, 2017 Jul 05.
Artigo em Inglês | MEDLINE | ID: mdl-28679382

RESUMO

BACKGROUND: Natural products have many uses and purposes, including those linked to pharmaceutics and cosmetics. The aim of this study was to investigate the use of natural remedies for the treatment of hair and scalp disorders in the West Bank, Palestine. METHODS: An ethnopharmacological survey of herbal remedies and other natural products used in cosmetics and cosmeceuticals was carried out in the West Bank, Palestine. A questionnaire was distributed to 267 herbalists, traditional healers, hairdressers and rural dwellers. Collected information included: the names of plants and other natural products, the parts used, hair conditions, diseases and problems for which these products were used and also their methods of preparation. To identify the most important species used, the factor of informant's consensus (Fic), fidelity level (Fl) and the use-value (UV) were calculated. RESULTS: Collected data showed that 41 plants are utilized for the treatment of hair and scalp disorders, belonging to 27 families; among them Lamiaceae and Rosaceae, which were the most commonly used. Plant oils and their fruits are the most commonly used parts. Hair loss, dandruff, split hair endings and lice treatment, are reported as the most treated disorders. The number of plant species used consisted of 19, 14, 13, and again 13 with a factor of informant's consensus (Fic) for these disorders corresponding to 0.93, 0.94, 0.95 and 0.92, respectively. Fl was 100% for many plants; the highest UV value (0.84) was registered for Lawsonia inermis, which belongs to the Lythraceae family. CONCLUSIONS: This study showed that many natural remedies are still used in Palestine for the treatment of scalp and hair disorders as well as for cosmeceutical purposes. This study is of great importance as it allows us to have a greater perspective on our folkloric use of these natural products. A combined scientific effort between informants and the scientific community, working in this field, may help in the discovery of new cosmetics, cosmeceutical and nutraceutical products.


Assuntos
Etnofarmacologia , Doenças do Cabelo/tratamento farmacológico , Medicina Tradicional/estatística & dados numéricos , Preparações de Plantas/uso terapêutico , Dermatoses do Couro Cabeludo/tratamento farmacológico , Adolescente , Adulto , Composição de Medicamentos , Feminino , Cabelo/efeitos dos fármacos , Doenças do Cabelo/etnologia , Humanos , Masculino , Pessoa de Meia-Idade , Oriente Médio/etnologia , Preparações de Plantas/química , Dermatoses do Couro Cabeludo/etnologia , Adulto Jovem
5.
J Pediatr Gastroenterol Nutr ; 64(1): 37-41, 2017 01.
Artigo em Inglês | MEDLINE | ID: mdl-28027214

RESUMO

BACKGROUND: Very early onset inflammatory bowel disease (VEOIBD) (inflammatory bowel disease [IBD] before 6 years of age) may manifest as a monogenic disease affecting the gastrointestinal tract. Syndromic diarrhea/trichohepatoenteric syndrome (SD/THE), a rare disorder caused by alteration of a complex involved in RNA degradation, has been reported to present with some degree of colitis and in some cases an IBD-like presentation. METHODS: We reviewed clinical and biological data of 4 previously published cases and added detailed data of 2 new cases of SD/THE with an IBD-like presentation. RESULTS: All the 6 patients presented with typical intractable diarrhea and hair abnormalities. The colon was affected in all of the patients: 1 had ileitis, 2 had panenteritis, and 2 presented with perianal disease. Fecal calprotectin level and erythrosedimentation rate were elevated in 2 cases each. All the therapeutic classes of IBD treatment (mesalazine, steroids, immunomodulators, and biological therapy) were used in the 6 cases. In 2 patients, treatment had no effect. Three showed a partial effect, and 1 patient sustained only a transient effect. CONCLUSIONS: SD/THE can have a similar presentation as VEOIBD, often as pancolitis. IBD treatments appear to have little efficacy for SD/THE, suggesting a different pathogenesis for the IBD-like features in SD/THE compared with classical IBD.


Assuntos
Colo/patologia , Diarreia Infantil/patologia , Retardo do Crescimento Fetal/patologia , Gastroenterite/etiologia , Doenças do Cabelo/patologia , Doenças Inflamatórias Intestinais/patologia , Intestino Delgado/patologia , Complexo Antígeno L1 Leucocitário/metabolismo , Anti-Inflamatórios/uso terapêutico , Terapia Biológica , Colite/etiologia , Diarreia/etiologia , Diarreia Infantil/tratamento farmacológico , Diarreia Infantil/metabolismo , Diarreia Infantil/terapia , Fácies , Fezes/química , Feminino , Retardo do Crescimento Fetal/tratamento farmacológico , Retardo do Crescimento Fetal/metabolismo , Retardo do Crescimento Fetal/terapia , Cabelo , Doenças do Cabelo/tratamento farmacológico , Doenças do Cabelo/metabolismo , Doenças do Cabelo/terapia , Humanos , Ileíte/etiologia , Fatores Imunológicos/uso terapêutico , Lactente , Recém-Nascido , Doenças Inflamatórias Intestinais/tratamento farmacológico , Doenças Inflamatórias Intestinais/metabolismo , Masculino , Mesalamina/uso terapêutico , Síndrome
6.
An Bras Dermatol ; 91(3): 331-5, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27438201

RESUMO

Silicon is the second most abundant element on Earth, and the third most abundant trace element in human body. It is present in water, plant and animal sources. On the skin, it is suggested that silicon is important for optimal collagen synthesis and activation of hydroxylating enzymes, improving skin strength and elasticity. Regarding hair benefits, it was suggested that a higher silicon content in the hair results in a lower rate of hair loss and increased brightness. For these beneficial effects, there is growing interest in scientific studies evaluating the efficacy and safety of using dietary supplements containing silicon. Its use aims at increasing blood levels of this element and improving the skin and its annexes appearance. There are different forms of silicon supplements available and the most important consideration to be made in order to select the best option is related to safety and bioavailability. Silicon supplements are widely used, though there is wide variation in silicon bioavailability, ranging from values below 1% up to values close to 50%, depending on the chemical form. Therefore, the aim of this study was to evaluate the scientific literature related to the different chemical forms of silicon supplements available and the limitations and recent progress in this field. According to reported studies, among the different chemical forms available, the orthosilicic acid (OSA) presents the higher bioavailability, whereas the others forms have absorption inversely proportional to the degree of polymerization. However, clinical studies evaluating safety and efficacy are still lacking.


Assuntos
Doenças do Cabelo , Ácido Silícico/farmacocinética , Silício/farmacocinética , Envelhecimento da Pele/efeitos dos fármacos , Disponibilidade Biológica , Colágeno/biossíntese , Suplementos Nutricionais , Doenças do Cabelo/tratamento farmacológico , Humanos , Doenças da Unha/tratamento farmacológico , Ácido Silícico/uso terapêutico , Silício/deficiência , Silício/fisiologia , Silício/uso terapêutico , Compostos de Silício/farmacocinética , Compostos de Silício/uso terapêutico , Envelhecimento da Pele/fisiologia
7.
An. bras. dermatol ; 91(3): 331-335,
Artigo em Inglês | LILACS | ID: lil-787284

RESUMO

Abstract Silicon is the second most abundant element on Earth, and the third most abundant trace element in human body. It is present in water, plant and animal sources. On the skin, it is suggested that silicon is important for optimal collagen synthesis and activation of hydroxylating enzymes, improving skin strength and elasticity. Regarding hair benefits, it was suggested that a higher silicon content in the hair results in a lower rate of hair loss and increased brightness. For these beneficial effects, there is growing interest in scientific studies evaluating the efficacy and safety of using dietary supplements containing silicon. Its use aims at increasing blood levels of this element and improving the skin and its annexes appearance. There are different forms of silicon supplements available and the most important consideration to be made in order to select the best option is related to safety and bioavailability. Silicon supplements are widely used, though there is wide variation in silicon bioavailability, ranging from values below 1% up to values close to 50%, depending on the chemical form. Therefore, the aim of this study was to evaluate the scientific literature related to the different chemical forms of silicon supplements available and the limitations and recent progress in this field. According to reported studies, among the different chemical forms available, the orthosilicic acid (OSA) presents the higher bioavailability, whereas the others forms have absorption inversely proportional to the degree of polymerization. However, clinical studies evaluating safety and efficacy are still lacking.


Assuntos
Humanos , Ácido Silícico/farmacocinética , Silício/farmacocinética , Envelhecimento da Pele/efeitos dos fármacos , Doenças do Cabelo , Ácido Silícico/uso terapêutico , Silício/deficiência , Silício/fisiologia , Silício/uso terapêutico , Disponibilidade Biológica , Envelhecimento da Pele/fisiologia , Colágeno/biossíntese , Compostos de Silício/uso terapêutico , Compostos de Silício/farmacocinética , Suplementos Nutricionais , Doenças do Cabelo/tratamento farmacológico , Doenças da Unha/tratamento farmacológico
9.
J Biomol Struct Dyn ; 32(10): 1613-23, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-23998289

RESUMO

Corticotropin-releasing factor (CRF) and corticotropin-releasing factor receptor (CRFR) play important roles in stress response, including anxiety and depression syndrome. The CRF expression also relates to chronic stress-related hair loss. This study utilizes the world's largest traditional Chinese medicine (TCM) database and molecular dynamics (MD) simulations to investigate novel CRFR inhibitors for treatment of alopecia. The docking and screening from TCM database results indicate the vitamin B2, 3 beta-isodihydrocadambine, and caribine display higher binding affinity than maltose in maltose binding protein (MBP). However, the results of MD simulation shows the caribine-facilitated CRFR approach closer to MBP, the 3D structure conformation of MBP and CRFR complex forms compact structure. Interestingly, the distance between the two proteins is reducing significantly after caribine dock into MBP binding site. Beside, from Ligand channel analysis, the paths of caribine demonstrate that residence time is increased in binding pocket. Hence, our finding suggests that caribine might be a potential lead compound to stimulate MBP and CRFR interaction, and help for baldless therapy in further study.


Assuntos
Medicamentos de Ervas Chinesas/farmacologia , Medicamentos de Ervas Chinesas/uso terapêutico , Doenças do Cabelo/tratamento farmacológico , Medicina Tradicional Chinesa , Receptores de Hormônio Liberador da Corticotropina/antagonistas & inibidores , Análise por Conglomerados , Medicamentos de Ervas Chinesas/química , Humanos , Ligantes , Simulação de Acoplamento Molecular , Análise de Componente Principal , Receptores de Hormônio Liberador da Corticotropina/metabolismo , Proteínas Recombinantes de Fusão/metabolismo , Termodinâmica
10.
Artigo em Inglês | MEDLINE | ID: mdl-23974582

RESUMO

The hair cosmetic industry has undergone a revolutionary change over the last two decades. The focus has dramatically veered from merely cleaning to repair, increasing the tensile strength, reducing oxidative damage, and stimulating growth. Newer shorter procedures to make hair look naturally more lustrous, smooth, and manageable have evolved. Specialized grooming products have been formulated to cleanse, calm, and condition the hair, and are tailored for different hair-types, for example, dry, dry-damaged, oily, colored, and gray hair. Other products are formulated to alter the color or structure of the hair shaft, for example, hair dyes, perming/relaxing. Hair sprays and waxes/gels, can alter the 'lift' of the hair-shaft. Although dermatologists are experts in managing scalp and hair diseases, the esthetic applications of newer cosmetic therapies still remain elusive. This article attempts to fill the lacunae in our knowledge of hair cosmetics and esthetic procedures relevant in today's rapidly changing beauty-enhancing industry, with special emphasis on the Indian scenario for chemical and 'natural' hair products.


Assuntos
Cor de Cabelo/efeitos dos fármacos , Doenças do Cabelo/tratamento farmacológico , Tinturas para Cabelo , Preparações para Cabelo/uso terapêutico , Medicina Herbária/métodos , Humanos , Índia
11.
Actas Dermosifiliogr ; 101(9): 749-57, 2010 Nov.
Artigo em Espanhol | MEDLINE | ID: mdl-21034705

RESUMO

Pseudofolliculitis barbae is a chronic, irritating, and potentially disfiguring condition that develops as a result of attempts to eliminate hair from the beard area, usually by shaving. It is difficult to determine the incidence of the disorder, but some studies report that it affects up to 1 of every 5 caucasian individuals and that it is much more common in black persons. Clinically it is characterized by the appearance of inflammatory papules and pustules. Once pseudofolliculitis has become established, treatment consists of avoiding shaving and the use of medical treatment similar to that used in acne. However, the long-term result is much more dependent on prevention through a correct shaving technique. In severe cases or when a definitive solution is sought, the treatment of choice is photodepilation.


Assuntos
Dermatoses Faciais/etiologia , Doenças do Cabelo/etiologia , Remoção de Cabelo/efeitos adversos , Peróxido de Benzoíla/uso terapêutico , População Negra , Cicatriz/etiologia , Cicatriz/prevenção & controle , Terapia Combinada , Fármacos Dermatológicos/uso terapêutico , Suscetibilidade a Doenças , Eflornitina/uso terapêutico , Dermatoses Faciais/tratamento farmacológico , Dermatoses Faciais/etnologia , Dermatoses Faciais/radioterapia , Feminino , Foliculite/tratamento farmacológico , Foliculite/etnologia , Foliculite/etiologia , Foliculite/radioterapia , Doenças do Cabelo/tratamento farmacológico , Doenças do Cabelo/etnologia , Doenças do Cabelo/radioterapia , Remoção de Cabelo/instrumentação , Remoção de Cabelo/métodos , Hirsutismo/complicações , Humanos , Hiperpigmentação/etiologia , Hiperpigmentação/prevenção & controle , Queloide/etiologia , Queloide/prevenção & controle , Lasers de Corante/uso terapêutico , Terapia com Luz de Baixa Intensidade , Masculino , Pigmentação da Pele , População Branca
12.
J Eur Acad Dermatol Venereol ; 24(4): 453-9, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19793151

RESUMO

BACKGROUND: Cetuximab is a chimeric human-murine monoclonal antibody against the epidermal growth factor receptor (EGFR). It has shown activities against multiple malignancies in clinical trials. EGFR-inhibitors (EGFRI) often cause skin toxicity, most frequently acneiform eruption. Xerosis, eczema, fissures, teleangiectases, nail changes and paronychia can be seen in some cases, rarely hyperpigmentation. MATERIALS AND METHODS: We reviewed local practice of skin toxicity management during treatment with cetuximab. From November 2005 to January 2007, 31 patients with metastatic colorectal cancer were treated with cetuximab in combination with chemotherapy. They all suffered from acne-like rash. They were followed up for at least 3 months, once per week. Skin toxicity was evaluated according to NCI CTCAE, v3.0. RESULTS: Of 31 patients, six had grade three rash, 16 patients Grade 2 and nine patients Grade 1 acne like rash. Less frequently, pruritus, dry skin, desquamation, hair modification, conjunctivitis, telangiectases, paronychia or fissures were observed. After the first documented cutaneous toxicity, topical use of emollients was started. For Grade 2 rash, we used emollients and topical antibiotics. Therapy with cetuximab was discontinued at Grade 3 until skin reactions resolved. Skin reactions at Grade 3 were generally manageable with emollients, topical and systemic antibiotics. No Grade 4 skin reactions were observed. CONCLUSION: During the treatment with EGFRI, it is necessary to recognize and manage adverse reactions promptly to assure better patient quality of life and allowing continuation of therapy without dose reduction or drug discontinuation.


Assuntos
Antibacterianos/administração & dosagem , Anticorpos Monoclonais/efeitos adversos , Antineoplásicos/efeitos adversos , Neoplasias Colorretais/tratamento farmacológico , Toxidermias/tratamento farmacológico , Emolientes/administração & dosagem , Erupções Acneiformes/induzido quimicamente , Erupções Acneiformes/tratamento farmacológico , Administração Tópica , Adulto , Idoso , Anticorpos Monoclonais/administração & dosagem , Anticorpos Monoclonais Humanizados , Antineoplásicos/administração & dosagem , Cetuximab , Neoplasias Colorretais/secundário , Conjuntivite/induzido quimicamente , Conjuntivite/tratamento farmacológico , Toxidermias/etiologia , Receptores ErbB/imunologia , Pestanas/efeitos dos fármacos , Feminino , Doenças do Cabelo/induzido quimicamente , Doenças do Cabelo/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Paroniquia/induzido quimicamente , Paroniquia/tratamento farmacológico , Qualidade de Vida , Telangiectasia/induzido quimicamente , Telangiectasia/tratamento farmacológico
14.
Yakugaku Zasshi ; 128(1): 11-20, 2008 Jan.
Artigo em Japonês | MEDLINE | ID: mdl-18176051

RESUMO

Hair follicles are the organs that produce hair shafts. They periodically regenerate throughout the life of the organisms, which is called the hair cycle. To develop new drugs to treat hair disorders and diseases, reproducible and high throughput assays or screening methods have been required to estimate the efficacy of various factors on hair follicle function. Although organ culture of hair follicles is one of the useful ways to carry out such research, it is not suitable for manipulating the genes or cells present in hair follicles. Patch assay is a method used to reconstruct hair follicles from enzymatically dissociated skin cells and has many advantages compared to the conventional Chamber method. Using the Patch method, transferring genes into follicular cells becomes easier than ever before. Chimeric follicles could be produced with dissociated cells by modifying the combination of cells or by simply merging cells of different origins. These applications certainly help the progress of hair research. However, we recently found that some functions of dermal papillae and follicular epithelia change during the growing phase (anagen) of the hair cycle. Dermal papillae produce different factors in early anagen and mid anagen. The signals from dermal papillae in early anagen could produce hair bulbs with clonogenic epithelial precursors but not with dormant epithelial precursors. On the other hand, the signals from dermal papillae in mid anagen strongly promote hair formation with dormant epithelial precursors. Therefore, more attention should be given to the hair cycle stages when using organ culture of hair follicles and conducting reconstruction experiments with follicularly derived cells.


Assuntos
Desenho de Fármacos , Doenças do Cabelo/tratamento farmacológico , Folículo Piloso , Técnicas de Cultura de Órgãos/métodos , Regeneração/fisiologia , Medicina Regenerativa/métodos , Animais , Proliferação de Células , Derme/citologia , Derme/transplante , Avaliação Pré-Clínica de Medicamentos , Células Epiteliais/citologia , Técnicas de Transferência de Genes , Folículo Piloso/citologia , Folículo Piloso/fisiologia , Humanos
15.
Pediatr Dermatol ; 24(3): E14-6, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17509110

RESUMO

We report a family affected to the fourth generation by uncombable hair syndrome. This syndrome is characterized by unruly, dry, blond hair with a tangled appearance. The family pedigree strongly supports the hypothesis of autosomal dominant inheritance; some members of the family had, apart from uncombable hair, minor signs of atopy and ectodermal dysplasia, such as abnormalities of the nails. The diagnosis was confirmed by means of extensive scanning electron microscopy. A trial with oral biotin 5 mg/day was started on two young patients with excellent results as regards the hair appearance, although scanning electron microscopy did not show structural changes in the hair. After a 2-year-period of follow-up, hair normality was maintained without biotin, while nail fragility still required biotin supplementation for control.


Assuntos
Biotina/uso terapêutico , Doenças do Cabelo/diagnóstico , Cabelo/ultraestrutura , Complexo Vitamínico B/uso terapêutico , Pré-Escolar , Cabelo/efeitos dos fármacos , Doenças do Cabelo/congênito , Doenças do Cabelo/tratamento farmacológico , Humanos , Masculino , Microscopia Eletrônica de Varredura , Doenças da Unha/complicações , Doenças da Unha/tratamento farmacológico
16.
J Gastroenterol Hepatol ; 16(1): 115-7, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11206309

RESUMO

Herbal preparations are widely available and generally regarded by the public as harmless remedies for a variety of medical ailments. We report the first case in Australia of acute hepatitis associated with the Chinese herbal medicine Shou-Wu-Pian, prepared from Polygonum multiflorum. Cholestatic hepatitis developed in a Chinese woman taking this preparation for the greying of her hair, and liver biopsy was consistent with a toxic reaction. Clinical and biochemical resolution occurred following cessation of the drug.


Assuntos
Doença Hepática Induzida por Substâncias e Drogas/etiologia , Medicamentos de Ervas Chinesas/efeitos adversos , Extratos Vegetais/efeitos adversos , Doença Aguda , Dor nas Costas/tratamento farmacológico , Constipação Intestinal/tratamento farmacológico , Medicamentos de Ervas Chinesas/uso terapêutico , Feminino , Doenças do Cabelo/tratamento farmacológico , Humanos , Testes de Função Hepática , Pessoa de Meia-Idade , Extratos Vegetais/uso terapêutico
18.
Vet Hum Toxicol ; 38(4): 280-2, 1996 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8829347

RESUMO

Hepatitis developed in a 31-y-old pregnant Chinese woman after consumption of Shou-Wu-Pian, a proprietary Chinese medicine prepared from Polygonum multiflorum. Tests for viral hepatitis were negative and there was no evidence of other systemic disease. The herbal preparation is commonly available in the Orient and China towns in western countries. Cases of herb-induced hepatitis reported in China are reviewed.


Assuntos
Doença Hepática Induzida por Substâncias e Drogas/fisiopatologia , Medicamentos de Ervas Chinesas/efeitos adversos , Extratos Vegetais/efeitos adversos , Plantas Medicinais/metabolismo , Administração Oral , Adulto , Biomarcadores/sangue , Medicamentos de Ervas Chinesas/administração & dosagem , Medicamentos de Ervas Chinesas/uso terapêutico , Feminino , Doenças do Cabelo/tratamento farmacológico , Hong Kong , Humanos , Extratos Vegetais/administração & dosagem , Extratos Vegetais/uso terapêutico , Gravidez
19.
J Am Anim Hosp Assoc ; 31(3): 250-3, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-7634061

RESUMO

Seven commonly used, topical antifungal products (i.e., lime sulfur, chlorhexidine, captan, povidone-iodine, sodium hypochlorite, and enilconazole solutions, and ketoconazole shampoo) were evaluated for their antifungal activity on Microsporum canis-infected hairs from dogs and cats in an in vitro study. Hairs were soaked or shampooed in each product for five minutes twice a week for four weeks. Of the seven products used in this study, lime sulfur and enilconazole solutions were superior in inhibiting fungal growth; no growth occurred on fungal cultures after two treatments with either product. Chlorhexidine and povidone iodine solutions were effective after four treatments, and sodium hypochlorite solution and ketoconazole shampoo inhibited fungal growth after eight treatments. Captan did not inhibit fungal growth during the test period.


Assuntos
Antifúngicos/uso terapêutico , Doenças do Gato/tratamento farmacológico , Dermatomicoses/veterinária , Doenças do Cão/tratamento farmacológico , Doenças do Cabelo/veterinária , Microsporum/efeitos dos fármacos , Administração Tópica , Animais , Antifúngicos/administração & dosagem , Doenças do Gato/microbiologia , Gatos , Dermatomicoses/tratamento farmacológico , Dermatomicoses/microbiologia , Doenças do Cão/microbiologia , Cães , Avaliação de Medicamentos/veterinária , Cabelo/microbiologia , Doenças do Cabelo/tratamento farmacológico , Doenças do Cabelo/microbiologia , Testes de Sensibilidade Microbiana/veterinária , Microsporum/isolamento & purificação
20.
J Pediatr ; 121(6): 890-5, 1992 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-1447651
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA